A new drug has the potential to change the way some cancers are treated. Scientists at two U.S. firms are working together on a drug, officially called PF-06647020, which targets some aggressive cancers that are notoriously hard to cure, including certain breast, ovarian and lung cancers. “We’re hoping to rip out the cancer by its …